Silo Pharma Inc stock is traded at $1.71, with a volume of 41,625. It is down -9.04% in the last 24 hours and up +42.50% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Previous Close:
$1.88
Open:
$1.78
24h Volume:
41,625
Relative Volume:
0.48
Market Cap:
$3.69M
Revenue:
$72,100
Net Income/Loss:
-$4.84M
P/E Ratio:
-
EPS:
-$7.46
Net Cash Flow:
-$3.84M
1W Performance:
-7.07%
1M Performance:
+42.50%
6M Performance:
-69.40%
1Y Performance:
-68.65%
1-Day Range:
$1.66$1.82
1-Week Range:
$1.47$2.00
52-Week Range:
$1.10$10.43
Silo Pharma Inc Stock (SILO) Company Profile
Name
Silo Pharma IncSector
HealthcareIndustry
BiotechnologyPhone
(718) 400-9031Address
677 N. WASHINGTON BLVD, SARASOTA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS